Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Stoke Therapeutics, Inc. | 17,786 | reported | 03 Jun 2026 | tx 8+151,595 |
| Loxo Oncology, Inc. | 0 | reported | 15 Feb 2019 | tx 136+210,500−210,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jun 2026 | GRANT_AWARD | Stoke Therapeutics, Inc. | 17,786 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 29,747 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Stoke Therapeutics, Inc. | 7,639 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Stoke Therapeutics, Inc. | 19,441 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | Stoke Therapeutics, Inc. | 21,000 | 0.00 USD | deriv |
| 08 Jun 2021 | GRANT_AWARD | Stoke Therapeutics, Inc. | 11,650 | 0.00 USD | deriv |
| 03 Jun 2020 | GRANT_AWARD | Stoke Therapeutics, Inc. | 14,777 | 0.00 USD | deriv |
| 10 Sept 2019 | GRANT_AWARD | Stoke Therapeutics, Inc. | 29,555 | 0.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 28,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 12,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 20,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 28,000 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 17,500 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 40,000 | 235.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | Loxo Oncology, Inc. | 20,000 | 0.00 USD | deriv |
| 11 Dec 2018 | EXERCISE | Loxo Oncology, Inc. | 1,250 | 11.35 USD | |
| 10 Dec 2018 | SALE | Loxo Oncology, Inc. | 100 | 133.34 USD | |
| 10 Dec 2018 | SALE | Loxo Oncology, Inc. | 400 | 132.44 USD | |
| 10 Dec 2018 | SALE | Loxo Oncology, Inc. | 550 | 134.71 USD | |
| 10 Dec 2018 | SALE | Loxo Oncology, Inc. | 100 | 136.04 USD | |
| 11 Dec 2018 | SALE | Loxo Oncology, Inc. | 200 | 135.69 USD | |
| 11 Dec 2018 | SALE | Loxo Oncology, Inc. | 587 | 136.98 USD | |
| 11 Dec 2018 | SALE | Loxo Oncology, Inc. | 263 | 137.88 USD | |
| 11 Dec 2018 | SALE | Loxo Oncology, Inc. | 100 | 139.36 USD | |
| 11 Dec 2018 | SALE | Loxo Oncology, Inc. | 100 | 140.48 USD |